
    
      This is a Single-center, Open-label, Single-arm,Non-randomized exploratory clinical trial
      evaluating the efficacy and safety of Apatinib plus XELOX regime as Neoadjuvant Therapy in
      Locally Advanced Gastric Cancer Patients With lymph node metastasis
    
  